Browse > Article
http://dx.doi.org/10.4014/jmb.1508.08059

Epidemiological Characterization of Opportunistic Mycoses between the Years 2006 and 2010 in Korea  

Park, Je-Seop (Department of Biomedical Laboratory Science, College of Medical Science, Konyang University)
Cho, Seung-Hak (Division of Enteric Diseases, Center for Infectious Diseases, Korea National Institute of Health)
Youn, Seung-Ki (Division of Quarantine Support, Korea Centers for Disease Control and Prevention)
Bak, Young-Seok (Department of Emergency Medical Service, College of Medical Science, Konyang University)
Yu, Young-Bin (Department of Biomedical Laboratory Science, College of Medical Science, Konyang University)
Kim, Young Kwon (Department of Biomedical Laboratory Science, College of Medical Science, Konyang University)
Publication Information
Journal of Microbiology and Biotechnology / v.26, no.1, 2016 , pp. 145-150 More about this Journal
Abstract
In order to perform an epidemiological characterization of opportunistic mycosis infections, we collected health insurance data between the years 2006 and 2010 from the Health Insurance Corporation and analyzed the data to determine the prevalence of opportunistic mycoses and treatment management of opportunistic mycoses. The prevalence within the study increased consecutively by 0.02% to 0.12% every year. The annual prevalence of opportunistic mycoses increased from 2.437% in 2006 to 2.709% in 2010. The average annual prevalence was 2.605%. Candidiasis occurred the most frequently, followed by aspergillosis, zygomycosis, and cryptococcosis. The regions with the highest incidences were the capital areas, Gyeonggi and Seoul. By sex, the prevalence in females (4.851%) was 14 times higher than that in males (0.352%). Interestingly, the adults from the 20- to 49-year-old age group showed higher prevalence than children and the elderly. The average duration of hospitalized treatment was 17.31 days and of outpatient treatment was 2.21 days; 3,577 hundred million won was used in total for medical expenses. This study provides useful data to study trends of opportunistic mycoses.
Keywords
Opportunistic mycoses; incidence rate; candidiasis; aspergillosis; cryptococcosis; zygomycosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ambrosioni J, Bouchuiguir-Wafa K, Garbino J. 2010. Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors. Int. J. Infect. Dis. 14: e100-e103.   DOI
2 Auberger J, Lass-Flörl C, Ulmer H, Nogler-Semenitz E, Clausen J, Gunsilius E, et al. 2008. Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int. J. Hematol. 88: 508-515.   DOI
3 Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, et al. 2006. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J. Clin. Microbiol. 44: 2816-2823.   DOI
4 Gonzalez GM, Elizondo M, Ayala J. 2008. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study. J. Clin. Microbiol. 46: 2902-2905.   DOI
5 Denning DW. 1996. Therapeutic outcome in invasive aspergillosis. Clin. Infect. Dis. 23: 608-615.   DOI
6 Eggimann P, Garbino J, Pittet D. 2003. Epidemiology of Candida species infection in critically ill non-immunosuppressed patients. Lancet Infect. Dis. 3: 685-702.   DOI
7 Garnacho-Montero J, Amaya-Villar R, Ortiz-Leyba C, León C, Alvarez-Lerma F, Nolla-Salas J, et al. 2005. Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit. Care 9: R191-R199.   DOI
8 Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, et al. 2003. Attributable mortality of nosocomial candidemia, revised. Clin. Infect. Dis. 37: 1172-1177.   DOI
9 Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, et al. 2004. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J. Clin. Microbiol. 42: 1519-1527.   DOI
10 Hoang LM, Maquire JA, Doyle P, Fyfe M, Roscoe DL. 2004. Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997–2002): epidemiology, microbiology and histopathology. J. Med. Microbiol. 53: 935-940.   DOI
11 Jain A, Jain S, Rawar S. 2010. Emerging fungal infections among children: a review on its clinical manifestations, diagnosis, and prevention. J. Pharm. Bioallied Sci. 2: 314-320.   DOI
12 Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, et al. 2010. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin. Infect. Dis. 50: 1091-1100.   DOI
13 Marr KA, Carter RA, Crippa F, Wald A, Corey L. 2002. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34: 909-917.   DOI
14 Javis WR. 1995. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 20: 1526-1530.   DOI
15 Kauffman CA. 2004. Zygomycosis: reemergence of an old pathogen. Clin. Infect. Dis. 39: 588-590.   DOI
16 McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, Warnock DW. 2001. Trends in mortality due to invasive mycotic diseases in the United States, 1908-1997.Clin. Infect. Dis. 33: 641-647.   DOI
17 Meis JF, Chakrabarti A. 2009. Changing epidemiology of an emerging infection: zygomycosis. Clin. Microbiol. Infect. 15: 10-14.   DOI
18 Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie-White S, Wilcox S, et al. 2005. Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect. Control Hosp. Epidemiol. 26: 540-547.   DOI
19 Nucci M, Queiroz-Telles F, Tobón AM, Restrepo A, Colombo AL. 2010. Epidemiology of opportunistic fungal infections in Latin America. Clin. Infect. Dis. 51: 561-570.   DOI
20 Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, et al. 2003. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin. Infect. Dis. 37: 634-643.   DOI
21 Pfaller MA. 2004. An epidemiologic update on invasive fungal infections. Adv. Stud. Med. 4: S269-S275.
22 Patterson TF, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, et al. 2000. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine 79: 250-260.   DOI
23 Perfect JR, Cox GM, Lee JY, Kauffman CA, de Repentigny L, Chapman SW, et al. 2001. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin. Infect. Dis. 33: 1824-1833.   DOI
24 Perusquía-Ortiz AM, Vázquez-González D, Bonifaz A. 2012. Opportunistic filamentous mycoses: aspergillosis, mucormycosis, phaeohyphomycosis and hyalohyphomycosis. J. Dtsch. Dermatol. Ges. 10: 611-621.
25 Pfaller MA, Pappas PG, Wingard JR. 2006. Invasive fungal pathogens: current epidemiological trends. Clin. Infect. Dis. 43: S3-S14.   DOI
26 Puzniak L, Teutsch S, Powderly W, Polish L. 2004. Has the epidemiology of nosocomial candidemia changed?. Infect. Control Hosp. Epidemiol. 25: 628-633.   DOI
27 Ribes JA, Vanover-Sams CL, Baker DJ. 2000. Zygomycetes in human disease. Clin. Microbiol. Rev. 13: 236-301.   DOI
28 Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. 2005. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin. Infect. Dis. 41: 634-653.   DOI
29 Slavin M, Fastenau J, Sukarom I, Marvos P, Crowley S, Gerth WC. 2004. Burden of hospitalization of patients with Candida and Aspergillus infections in Australia. Int. J. Infect. Dis. 8: 111-120.   DOI
30 Warnock DW, Hajjeh RA, Lasker BA. 2001. Epidemiology and prevention of invasive aspergillosis. Curr. Infect. Dis. Rep. 3: 507-516.   DOI
31 Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. 2005. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin. Infect. Dis. 41: 1232-1239.   DOI
32 Warnock DW. 2007. Trends in the epidemiology of invasive fungal infections. Jpn. J. Med. Mycol. 48: 1-12.   DOI
33 Wenzel RP, Gennings C. 2005. Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies. Clin. Infect. Dis. 41: S389-S393.   DOI
34 Yamazaki T, Kume H, Murase S, Yamashita E, Arisawa M. 1999. Epidemiology of visceral mycoses: analysis of data in annual of the pathological autopsy cases in Japan. J. Clin. Microbiol. 37: 1732-1738.
35 Zilberberg MD, Shorr AF, Kollef MH. 2008. Secular trends in candidemia-related hospitalization in the United States, 2000–2005. Infect. Control Hosp. Epidemiol. 29: 978-980   DOI